Dragon Life Science Holdings Group, Inc. (NOHO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | 213.14 Thousand | 1428.00 | 1528.00 | 3747.50 |
| Selling, General and Administrative Expenses | - | - | 213.14 Thousand | 1428.00 | 1528.00 | 3747.50 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | 213.14 Thousand | 1428.00 | 1528.00 | 3747.50 |
| Operating Income | - | - | -213.15 Thousand | -1430.00 | -1530.00 | -3750.00 |
| Interest Expense | - | - | 51.04 Thousand | 42.82 Thousand | 138.89 Thousand | - |
| Income Tax Expense | - | - | -236.55 Thousand | -206.29 Thousand | -171.86 Thousand | - |
| Earnings before Tax | - | - | -264.19 Thousand | -44.25 Thousand | -140.42 Thousand | -3747.50 |
| Net Income | - | - | -264.19 Thousand | -44.25 Thousand | -140.42 Thousand | -3747.50 |
| Earnings Per Share Basic | - | - | - | - | - | - |
| Earnings Per Share Diluted | - | - | - | - | - | - |
| Weighted Average Shares Outstanding | - | - | 11.85 Billion | 8.57 Billion | 8.57 Billion | 8.57 Billion |
| Weighted Average Shares Outstanding (Diluted) | - | - | 11.85 Billion | 8.57 Billion | 8.57 Billion | 8.57 Billion |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | -213.15 Thousand | -1430.00 | -1530.00 | -3747.50 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2022 FY | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | 1834.00 | 1729.00 | - | - | - |
| Cost of Revenue | - | 1809.00 | 2859.00 | - | - | - |
| Gross Profit | - | 25.00 | -1130.00 | - | - | - |
| Operating Expenses | - | 137.23 Thousand | 117.81 Thousand | - | 52.93 Thousand | 53.68 Thousand |
| Selling, General and Administrative Expenses | - | 137.23 Thousand | 117.81 Thousand | - | 52.93 Thousand | 53.68 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | 139.04 Thousand | 120.67 Thousand | - | 52.93 Thousand | 53.68 Thousand |
| Operating Income | - | -137.21 Thousand | -118.95 Thousand | - | -52.93 Thousand | -53.69 Thousand |
| Interest Expense | - | 36.34 Thousand | 44.46 Thousand | - | 220.36 Thousand | 204.64 |
| Income Tax Expense | - | 39.58 Thousand | -122.08 Thousand | - | - | - |
| Earnings before Tax | - | -272.92 Thousand | -51.21 Thousand | - | 1.34 Million | -41.19 Thousand |
| Net Income | - | -272.92 Thousand | -51.21 Thousand | - | 1.34 Million | -41.19 Thousand |
| Earnings Per Share Basic | - | - | - | - | 0.00 | - |
| Earnings Per Share Diluted | - | - | - | - | 0.00 | - |
| Weighted Average Shares Outstanding | - | 20.04 Billion | 20.04 Billion | - | 13.75 Billion | 13.25 Billion |
| Weighted Average Shares Outstanding (Diluted) | - | 20.04 Billion | 20.04 Billion | - | 13.75 Billion | 13.25 Billion |
| Gross Margin | - | 0.01 | -0.65 | - | - | - |
| EBIT Margin | - | -74.81 | -68.80 | - | - | - |
| Profit Margin | - | -148.81 | -29.62 | - | - | - |
| EBITDA | - | -137.21 Thousand | -118.95 Thousand | - | -52.93 Thousand | -53.69 Thousand |
| Earnings Before Tax Margin | - | -74.81 | -68.80 | - | - | - |
009200
FAGA
JSWINFRA
0200
600717
CONCHATORO